Evidence map›Paper›PMID 26253825›Full record

ArticleWomen's health issues : official publication of the Jacobs Institute of Women's Health

Beliefs About Anal Cancer among HIV-Infected Women: Barriers and Motivators to Participation in Research.

Tracy A Battaglia, Christine M Gunn, Molly E McCoy, Helen H Mu, Amy S Baranoski, Elizabeth Y Chiao, Lisa A Kachnic, Elizabeth A Stier

Open access · greenAbstract read
In one paragraph

Article in Women's health issues : official publication of the Jacobs Institute of Women's Health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Addressing Barriers to Clinical Trial Participation for Transgender People With Cancer to Improve Access and Generate Data.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Tracy A BattagliaWomen's Health Unit, Section of General Internal Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.
Christine M GunnWomen's Health Unit, Section of General Internal Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts. Electronic address: Christine.Gunn@bmc.org.
Molly E McCoyWomen's Health Unit, Section of General Internal Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.
Helen H MuDepartment of Obstetrics and Gynecology, Boston University Medical Center, Boston, Massachusetts.
Amy S BaranoskiDivision of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania.
Elizabeth Y ChiaoDepartment of Medicine, Baylor College of Medicine, Houston Health Services Research and Development Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
Lisa A KachnicDepartment of Radiation Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.
Elizabeth A StierDepartment of Obstetrics and Gynecology, Boston University Medical Center, Boston, Massachusetts.
Boston University · USBoston Medical Center · USDrexel University · USHealth Services Research & Development · USUniversity Medical Center · US

Funding

Consortium for Advancing Management and Prevention of Cancer in People with HIVUM1CA121947 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Joseph A. Sparano · 2015 to 2026
$253.7M
University of Southern CaliforniaU01CA121947 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MITSUYASU, RONALD T. · 2006 to 2014
$54.7M
"Patient Navigation in the SafetyNet: CONNECTeDD"U01CA116892 · NCI · BOSTON MEDICAL CENTER · PI FREUND, KAREN · 2005 to 2010
$4.3M
The MB-CCOP at Boston Medical CenterU10CA139519 · NCI · BOSTON MEDICAL CENTER · PI KACHNIC, LISA A. · 2010 to 2014
$3.3M
The Effectiveness of Screening HIV-Infected Women for Anal Cancer PrecursorsR01CA163103 · NCI · BAYLOR COLLEGE OF MEDICINE · PI CHIAO, ELIZABETH Y. · 2011 to 2015
$2.8M
NCI NIH HHS 1U-10CA129519-01A1NCI NIH HHS R01 CA163103NCI NIH HHS U01 CA116892NCI NIH HHS U01 CA116892-0551NCI NIH HHS U01 CA121947NCI NIH HHS U10 CA139519NCI NIH HHS U10 CA139519-02SNCI NIH HHS UM1 CA121947
6 · The paper itself

Abstract

backgroundInfection with the human immunodeficiency virus (HIV) remains associated with a greater risk of anal cancer, despite widespread use of combination antiretroviral therapy. Evidence concerning the acceptability of anal cancer screening gives little attention to women. Because HIV-infected women have a high prevalence of depression and history of sexual trauma, understanding acceptability among this group is critical. PURPOSE: We sought to assess barriers and motivators to participation in anal cancer screening research among a racial/ethnically diverse HIV-infected female population.

methodsWe conducted a survey based on the Health Belief Model to identify characteristics of women willing to participate in anal cancer screening research (n = 200). Bivariate analyses examined associations between willingness to participate and sociodemographics, clinical characteristics, and health beliefs. Logistic regression modeled willingness to participate in research. MAIN

findingsOf the women who participated, 37% screened positive for depression, 43% reported a high trauma history, and 36% screened positive for posttraumatic stress disorder. Overall, 65% reported willingness to participate in research. Those likely to participate were older, reported intravenous drug use as their HIV risk factor, and had a history of prior high-resolution anoscopy (HRA) compared with those unwilling to participate. The most commonly reported barrier to anal Pap testing was fear of pain. In adjusted analyses, a lack of fear of pain and prior experience with HRA significantly predicted willingness to participate.

conclusionsFindings suggest that, to increase participation in anal Pap and HRA-related research for HIV-infected women, a single approach may not be adequate. Rather, we must harness patients' previous experiences and address psychosocial and financial concerns to overcome barriers to participation.

Indexed as

Attitude to HealthMotivationAdultAnus NeoplasmsBiomedical ResearchCross-Sectional StudiesFemaleHIV InfectionsHumansMiddle AgedPatient ParticipationRisk FactorsSocioeconomic FactorsSurveys and QuestionnairesTrustVulnerable Populations

Identifiers

PMID26253825
PMCPMC4641840
OpenAlexW2095868803

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.